Uncategorized

Chiesi signs $1.9B deal to acquire KalVista and its approved drug

Chiesi signs $1.9B deal to acquire KalVista and its approved drug

Published

4 days ago

on

April 29, 2026

By

Temp User

Chiesi is buying commercial biotech KalVista Pharmaceuticals for about $1.9 billion in an extension of the industry’s vigorous spring shopping spree.

The Italian pharma will pay $27 per share {$KALV} in cash to buy the … Read More

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

The old and New Edition cast comes together to perform

Exit mobile version